Table 3. Management of participants and lung cancer diagnosis after the first LDCT scan at baseline screening round according to NCCN and EUPS protocols.
| Management | NCCN protocol | EUPS diameter protocol | EUPS volume protocol |
|---|---|---|---|
| All participants (n=1,000) | |||
| Next screening | 949 (94.9%) | 889 (88.9%) | 936 (93.6%) |
| Short-term repeat (3/6 months) | 45 (4.5%) | 97 (9.7%) | 45 (4.5%) |
| Referral to a pulmonologist | 6 (0.6%) | 14 (1.4%) | 19 (1.9%) |
| Participants with solid nodule (n=103) | |||
| Next screening | 57 (55.3%) | 13 (12.6%) | 45 (43.7%) |
| Short-term repeat (3/6 months) | 42 (40.8%) | 76 (73.8%) | 43 (41.7%) |
| Referral to a pulmonologist | 4 (3.8%) | 14 (13.6%) | 15 (14.6%) |
| Participants with part-solid nodule (n=5) | |||
| Next screening | 0 | 0 | 0 |
| Short-term repeat (3/6 months) | 3 | 5 | 1 |
| Referral to a pulmonologist | 2 | 0 | 4 |
| Participants with non-solid nodule (n=16) | |||
| Next screening | 16 | 0 | 15 |
| Short-term repeat (3/6 months) | 0 | 16 | 1 |
| Referral to a pulmonologist | 0 | 0 | 0 |
| Participants without nodules (n=876) | |||
| Next screening | 876 | 876 | 876 |
| No. of lung cancer diagnosis until (including) second round | 10 | 10 | 10 |
LDCT, low-dose computed tomography; NCCN, National Comprehensive Cancer Network; EUPS, European Position Statement.